Francesco Berardi

发表

High-Throughput Analysis of the Drug Mode of Action of PB28, MC18 and MC70, Three Cyclohexylpiperazine Derivative New Molecules

Vitoantonio Bevilacqua, Paolo Pannarale, Diego di Bernardo, 2008, ICIC.

Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview

Giovanni Laviola, Walter Adriani, Francesco Berardi, 2014, Reviews in the neurosciences.

5-HT 7 receptor modulators: a medicinal chemistry survey

Francesco Berardi, Roberto Perrone, E. Lacivita, 2010 .

Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands for visualization of brain dopamine D3 receptors.

Francesco Berardi, Roberto Perrone, E. Lacivita, 2006, Journal of medicinal chemistry.

Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor.

Anders Ettrup, Szabolcs Lehel, Matthias M Herth, 2014, Bioorganic & medicinal chemistry.

Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands.

Vincenzo Tortorella, Francesco Berardi, Roberto Perrone, 2002, Journal of medicinal chemistry.

Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins.

Giancarlo Albo, Francesco Berardi, Roberto Perrone, 2008, European journal of pharmacology.

Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences

Massimo Zucchetti, Nicola A. Colabufo, Jian Ming Xu, 2009, Cancer Chemotherapy and Pharmacology.

5-HT7 receptor modulators: a medicinal chemistry survey of recent patent literature (2004 – 2009)

Francesco Berardi, Roberto Perrone, E. Lacivita, 2010, Expert opinion on therapeutic patents.

Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials.

Francesco Berardi, Roberto Perrone, F. Berardi, 2010, Journal of medicinal chemistry.

Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.

Francesco Berardi, Roberto Perrone, E. Lacivita, 2007, Journal of medicinal chemistry.